Cover Image
市場調查報告書

SK Chemicals Co., Ltd. : 產品平台分析

SK Chemicals Co., Ltd. - Product Pipeline Review - 2016

出版商 Global Markets Direct 商品編碼 293899
出版日期 內容資訊 英文 52 Pages
訂單完成後即時交付
價格
Back to Top
SK Chemicals Co., Ltd. : 產品平台分析 SK Chemicals Co., Ltd. - Product Pipeline Review - 2016
出版日期: 2016年05月25日 內容資訊: 英文 52 Pages
簡介

SK Chemicals Co., Ltd.致力於開發9個治療領域的潛力臨床藥候補。其領域分別為感染疾病、男性健康、肌肉骨骼障礙、女性健康、代謝性障礙、尿道生殖器·性荷爾蒙系統、血液疾病、皮膚科學、及未公佈的症狀等。這些領域的市場需求高,開發治療用化合物不僅對患者有益,更有加深製藥公司彼此合作的效果。

本報告提供SK Chemicals Co., Ltd.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

SK Chemicals Co., Ltd.的基本資料

  • SK Chemicals Co., Ltd.概要
  • 主要資訊
  • 企業資料

SK Chemicals Co., Ltd.:R&D概要

  • 主要的治療範圍

SK Chemicals Co., Ltd.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 合作夥伴產品
    • 合作夥伴產品/聯合治療模式

SK Chemicals Co., Ltd.:開發中產品概況

  • 後期階段產品開發中產品
    • 預註冊產品/聯合治療模式
    • 第Ⅲ期的產品/聯合治療模式
  • 臨床實驗階段的開發中產品
    • 第Ⅰ期的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發產品/聯合治療模式

SK Chemicals Co., Ltd.:開發階段不明的開發中產品

  • 開發階段不明的產品/聯合治療模式

SK Chemicals Co., Ltd.:藥物簡介

SK Chemicals Co., Ltd.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

SK Chemicals Co., Ltd.:最近的開發平台趨勢

SK Chemicals Co., Ltd.:暫停中的計劃

SK Chemicals Co., Ltd.:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC08054CDB

Summary

Global Markets Direct's, 'SK Chemicals Co., Ltd. - Product Pipeline Review - 2016', provides an overview of the SK Chemicals Co., Ltd.'s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by SK Chemicals Co., Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of SK Chemicals Co., Ltd.
  • The report provides overview of SK Chemicals Co., Ltd. including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses SK Chemicals Co., Ltd.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features SK Chemicals Co., Ltd.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

  • Evaluate SK Chemicals Co., Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for SK Chemicals Co., Ltd.
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding SK Chemicals Co., Ltd.'s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • SK Chemicals Co., Ltd. Snapshot
    • SK Chemicals Co., Ltd. Overview
    • Key Information
    • Key Facts
  • SK Chemicals Co., Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • SK Chemicals Co., Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • SK Chemicals Co., Ltd. - Pipeline Products Glance
    • SK Chemicals Co., Ltd. - Late Stage Pipeline Products
      • Pre-Registration Products/Combination Treatment Modalities
      • Phase III Products/Combination Treatment Modalities
    • SK Chemicals Co., Ltd. - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • SK Chemicals Co., Ltd. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • SK Chemicals Co., Ltd. - Drug Profiles
    • antihemophilic factor (recombinant)
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NBP-603
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NBP-606
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NBP-607
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • THVD-201
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NBP-608
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NCE-403
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SKI-2670
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NBP-604
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NBP-611
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NCE-401
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NCE-402
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NCE-405
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SID-111
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SID-910
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SID-920
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SKI-2162
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • typhoid vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Vaccine 2 for Undisclosed Indication
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • pneumonia vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • SK Chemicals Co., Ltd. - Pipeline Analysis
    • SK Chemicals Co., Ltd. - Pipeline Products by Target
    • SK Chemicals Co., Ltd. - Pipeline Products by Route of Administration
    • SK Chemicals Co., Ltd. - Pipeline Products by Molecule Type
    • SK Chemicals Co., Ltd. - Pipeline Products by Mechanism of Action
  • SK Chemicals Co., Ltd. - Recent Pipeline Updates
  • SK Chemicals Co., Ltd. - Dormant Projects
  • SK Chemicals Co., Ltd. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • SK Chemicals Co., Ltd., Key Information
  • SK Chemicals Co., Ltd., Key Facts
  • SK Chemicals Co., Ltd. - Pipeline by Indication, 2016
  • SK Chemicals Co., Ltd. - Pipeline by Stage of Development, 2016
  • SK Chemicals Co., Ltd. - Monotherapy Products in Pipeline, 2016
  • SK Chemicals Co., Ltd. - Partnered Products in Pipeline, 2016
  • SK Chemicals Co., Ltd. - Partnered Products/ Combination Treatment Modalities, 2016
  • SK Chemicals Co., Ltd. - Pre-Registration, 2016
  • SK Chemicals Co., Ltd. - Phase III, 2016
  • SK Chemicals Co., Ltd. - Phase I, 2016
  • SK Chemicals Co., Ltd. - Preclinical, 2016
  • SK Chemicals Co., Ltd. - Discovery, 2016
  • SK Chemicals Co., Ltd. - Pipeline by Target, 2016
  • SK Chemicals Co., Ltd. - Pipeline by Route of Administration, 2016
  • SK Chemicals Co., Ltd. - Pipeline by Molecule Type, 2016
  • SK Chemicals Co., Ltd. - Pipeline Products by Mechanism of Action, 2016
  • SK Chemicals Co., Ltd. - Recent Pipeline Updates, 2016
  • SK Chemicals Co., Ltd. - Dormant Developmental Projects,2016
  • SK Chemicals Co., Ltd., Other Locations
  • SK Chemicals Co., Ltd., Subsidiaries

List of Figures

  • SK Chemicals Co., Ltd. - Pipeline by Top 10 Indication, 2016
  • SK Chemicals Co., Ltd. - Pipeline by Stage of Development, 2016
  • SK Chemicals Co., Ltd. - Monotherapy Products in Pipeline, 2016
  • SK Chemicals Co., Ltd. - Partnered Products in Pipeline, 2016
  • SK Chemicals Co., Ltd. - Pipeline by Top 10 Target, 2016
  • SK Chemicals Co., Ltd. - Pipeline by Route of Administration, 2016
  • SK Chemicals Co., Ltd. - Pipeline by Molecule Type, 2016
  • SK Chemicals Co., Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2016
Back to Top